Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LY3475070 |
Trade Name | |
Synonyms | LY-3475070|LY 3475070 |
Drug Descriptions |
LY3475070 is a CD73 inhibitor, which inhibits conversion of adenosine monophosphate (AMP) to adenosine to prevent suppression of the anti-tumor response (NCI Thesaurus). |
DrugClasses | Adenosine Targeting 23 |
CAS Registry Number | NA |
NCIT ID | C170952 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
LY3475070 | LY3475070 | 0 | 1 |
LY3475070 + Pembrolizumab | LY3475070 Pembrolizumab | 0 | 1 |